[Significance of lipase and amylase activity inhibition through various antibiotics and sulfonamides for the therapy of acute pancreatic disease].
D000208:Acute Disease; D000667:Ampicillin / Q000627:therapeutic use; D000681:Amylases / Q000037:antagonists & inhibitors* / Q000097:blood; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002701:Chloramphenicol / Q000627:therapeutic use; D006801:Humans; D008049:Lipase / Q000037:antagonists & inhibitors* / Q000097:blood; D010195:Pancreatitis / Q000188:drug therapy / Q000201:enzymology*; D013449:Sulfonamides / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D002701:Chloramphenicol; D000667:Ampicillin; D008049:Lipase; D000681:Amylases; D013752:Tetracycline
Zur Bedeutung der Hammbarkeit der Lipase- und Amylaseaktivität durch einige Antibiotika und Sulfonamide für die Therapei akuter Pankreaserkrankungen.